IOVA

Iovance Biotherapeutics Inc

May 15 • 04:00PM ET

3.45

-0.07 -1.99 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: LYEL ALLO AUTL SANA BEAM

| Held by: VTI XBI IWM VB VXF IWN VBR IBB VTWO SCHA

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.95	Insider Own	14.22%	Shs Outstand	438.11M	Perf Week	-4.70%
Market Cap	1.54B	Forward P/E	-	EPS next Y	-0.31	Insider Trans	0.00%	Shs Float	387.94M	Perf Month	-9.21%
Enterprise Value	1.27B	PEG	-	EPS next Q	-0.13	Inst Own	55.77%	Short Float	29.57%	Perf Quarter	34.24%
Income	-353.86M	P/S	5.39	EPS this Y	49.65%	Inst Trans	10.50%	Short Ratio	6.69	Perf Half Y	35.83%
Sales	285.55M	P/B	2.09	EPS next Y	43.59%	ROA	-37.40%	Short Interest	114.71M	Perf YTD	26.37%
Book/sh	1.65	P/C	4.91	EPS next 5Y	-	ROE	-47.51%	52W High	5.63 -38.72%	Perf Year	96.02%
Cash/sh	0.70	P/FCF	-	EPS past 3/5Y	23.93% 10.23%	ROIC	-46.22%	52W Low	1.64 110.56%	Perf 3Y	-55.99%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	25.04%	Volatility	6.62% 6.81%	Perf 5Y	-86.64%
Dividend TTM	-	EV/Sales	4.46	EPS Y/Y TTM	23.00%	Oper. Margin	-125.41%	ATR (14)	0.27	Perf 10Y	-30.30%
Dividend Ex-Date	-	Quick Ratio	3.15	Sales Y/Y TTM	34.26%	Profit Margin	-123.92%	RSI (14)	45.50	Recom	1.50
Dividend Gr. 3/5Y	- -	Current Ratio	3.60	EPS Q/Q	47.50%	SMA20	-3.89%	Beta	0.67	Target Price	8.80
Payout	-	Debt/Eq	0.07	Sales Q/Q	44.82%	SMA50	-8.22%	Rel Volume	0.44	Prev Close	3.52
Employees	975	LT Debt/Eq	0.06	Earnings	May 07 BMO	SMA200	23.32%	Avg Volume	17.14M	Price	3.45
IPO	Sep 01, 2009	Option/Short	Yes / Yes	EPS/Sales Surpr.	-23.70% -8.23%	Trades		Volume	7,837,137	Change	-1.99%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)